Notably, tumour-infiltrating lymphocytes with a Trm phenotype were increased in numbers and frequencies within CD45+ cells more than tenfold in average upon anti-PD-1 treatment in both tumour settings (Fig. 6f,g and Supplementary Fig. 3c). Here, PTPRC is linked to neoplasm.